The UK MRC and South African MRC (SAMRC) are pleased to invite proposals to the South Africa – UK Antibiotic Accelerator under the umbrella of the Newton Fund.
This initiative will provide funding for high quality collaborative research partnerships focused on addressing the growing global burden of antimicrobial resistance, specifically antibacterial resistance in (South) Africa, through drug discovery.
In total, the MRC will make up to £2 million available to support the antibiotic accelerator over a three-year period. The UK contribution will be matched by SAMRC who will provide up to R24 million.